Polyrizon Ltd. (NASDAQ:PLRZ) Short Interest Down 57.2% in January

Polyrizon Ltd. (NASDAQ:PLRZ) saw a significant drop in short interest during the month of January. As of January 30th, there was short interest totaling 51,385 shares, a drop of 57.2% from the January 15th total of 120,032 shares. Approximately 4.9% of the shares of the company are short sold. Based on an average daily trading volume, of 71,761 shares, the days-to-cover ratio is presently 0.7 days. Based on an average daily trading volume, of 71,761 shares, the days-to-cover ratio is presently 0.7 days. Approximately 4.9% of the shares of the company are short sold.

Polyrizon Trading Up 8.9%

Shares of NASDAQ:PLRZ traded up $1.14 on Thursday, hitting $13.99. The company’s stock had a trading volume of 64,063 shares, compared to its average volume of 138,233. Polyrizon has a 12 month low of $2.88 and a 12 month high of $2,235.00. The stock’s 50-day moving average is $12.33 and its two-hundred day moving average is $8.30.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Polyrizon in a research report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Polyrizon presently has an average rating of “Sell”.

About Polyrizon

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.